Editorial Article
The NanoTemper Success Story – Massive Growth Follows One Great Innovation
Dream big, don’t be limited by current opinion and don’t be afraid to make mistakes – co-CEO Dr. Stefan Duhr shares his tips for success and more
Dream big, don’t be limited by current opinion and don’t be afraid to make mistakes – co-CEO Dr. Stefan Duhr shares his tips for success and more
AEOL 10150 is currently the only drug being developed by BARDA to address the delayed effects of radiation exposure
Learn how the team at NanoTemper Technologies is helping scientists design better assays and quickly generate meaningful results
SelectScience is excited to be attending AACR 2017, Washington D.C., USA
Global leaders convene to map new paths to diagnose and treat Alzheimer’s, Multiple Sclerosis, and other neurodegenerative diseases that afflict one in six people
Find out how precise affinity measurements can enable the generation of tailor-made binding proteins